Literature DB >> 1506165

A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology.

H Amital-Teplizki1, J E Bearman, P W Miele, S Sukenik, Y Shoenfeld.   

Abstract

Utilizing a newly perfected multiple-response permutation procedure, we analyzed the autoantibody titer of systemic lupus erythematosus (SLE) patients during active and convalescent periods of disease, SLE patients without neurological involvement, and three other comparison groups (patients with active tuberculosis, patients with multiple sclerosis, and healthy normal controls). The multidimensional analysis we used distinguished those SLE patients with neurological involvement from the other SLE patients. Differences were noted by a univariate analysis measuring antibodies to single- and double-stranded DNA, poly (G), Sm, RNP, Ro, La, and gangliosides. Elevated concentrations of the common anti-DNA idiotype 16/6 were also noted among SLE patients with neuropsychiatric illness. This report stresses that increased disease activity in SLE patients with neuropsychiatric phenomena is reflected by their autoantibody profile.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506165

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  3 in total

1.  Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens.

Authors:  I J Alosachie; J W Terryberry; D Mevorach; Y Chapman; M Lorber; D Torre; P Youinou; J B Peter; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Neuropsychiatric Symptoms in Lupus.

Authors:  Maria Gulinello; Jing Wen; Chaim Putterman
Journal:  Psychiatr Ann       Date:  2012-09

3.  16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.

Authors:  Shaye Kivity; Aviva Katzav; Maria Teresa Arango; Moran Landau-Rabi; Yaron Zafrir; Nancy Agmon-Levin; Miri Blank; Juan-Manuel Anaya; Edna Mozes; Joab Chapman; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.